We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Embryo Engineering Breakthrough Generates Controversy

By Biotechdaily staff writers
Posted on 05 Jun 2008
Stem cell researchers have genetically engineered a human embryo, a pioneering development that was immediately criticized as a big step toward engineering infants. More...


The research itself was very simple: After positioning a fluorescent protein gene into an embryo all the cells in the embryo glowed after it divided, giving researchers a chance to monitor the changes that had been engineered. The scientists emphasized that their study was performed on a nonviable embryo that could never have grown into an infant.

The research, first covered on May 11, 2008, in the Sunday edition of the New York Times, was criticized by the Center for Genetics and Society (Oakland, CA, USA) for crossing a boundary that had never been breached. Their worry is that once researchers understand how to engineer an embryo, individuals can design their babies with specific characteristics for intelligence, appearance, or athletic ability. However, the scientists insisted that their study should not be misinterpreted.

"None of us wants to make designer babies,” said Dr. Zev Rosenwaks, director of the Center for Reproductive Medicine and Infertility at New York-Presbyterian/Weill Cornell Medical Center (New York, NY,USA).


Related Links:
New York-Presbyterian/Weill Cornell Medical Center

Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Automated MALDI-TOF MS System
EXS 3000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Industry

view channel
Image: The initiative aims to speed next-generation diagnostic development during early pathogen emergence (photo courtesy of 123RF)

Cepheid Joins CDC Initiative to Strengthen U.S. Pandemic Testing Preparednesss

Cepheid (Sunnyvale, CA, USA) has been selected by the U.S. Centers for Disease Control and Prevention (CDC) as one of four national collaborators in a federal initiative to speed rapid diagnostic technologies... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.